These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 16711513

  • 1. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN, van Trommel NE, Sweep FC, Massuger LF, Thomas CM.
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [Abstract] [Full Text] [Related]

  • 2. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

  • 3. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE, Sweep FC, Ross HA, Massuger LF, Thomas CM.
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [Abstract] [Full Text] [Related]

  • 4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 5. Early identification of persistent trophoblastic disease with serum hCG concentration ratios.
    van Trommel NE, Ngo Duc H, Massuger LF, Schijf CP, Sweep CG, Thomas CM, Dutch Working Party on Trophoblastic Tumors.
    Int J Gynecol Cancer; 2008 Apr; 18(2):318-23. PubMed ID: 17511799
    [Abstract] [Full Text] [Related]

  • 6. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J, Ohba T, Fukunaga M, Katabuchi H.
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [Abstract] [Full Text] [Related]

  • 7. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I, Vejerslev LO, Frøding L, Blaakær J, Maroun LL, Hansen ES, Grove A, Lund H, Havsteen H, Sunde L.
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [Abstract] [Full Text] [Related]

  • 8. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C, Sweep FC, Ottevanger PB, Massuger LF, Thomas CM.
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [Abstract] [Full Text] [Related]

  • 9. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
    Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, van Herwaarden A.
    Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
    [Abstract] [Full Text] [Related]

  • 10. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 11. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM, Thomas CM, Quinn MA, McNally OM, Bekkers RL.
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [Abstract] [Full Text] [Related]

  • 12. Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve.
    Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, Thomas CM.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):787-92. PubMed ID: 7681253
    [Abstract] [Full Text] [Related]

  • 13. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL.
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 15. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 16. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 17. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [Abstract] [Full Text] [Related]

  • 18. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
    Badonnel Y, Barbé F, Legagneur H, Poncelet E, Schweitzer M.
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
    [Abstract] [Full Text] [Related]

  • 19. Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.
    Rakprasit C, Ruengkhachorn I, Therasakvichya S, Inthasorn P, Achariyapota V, Kuljarasnont S, Khemworapong K, Jareemit N.
    Arch Gynecol Obstet; 2023 Apr; 307(4):1145-1154. PubMed ID: 36116082
    [Abstract] [Full Text] [Related]

  • 20. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.